Serum biomarkers in metastatic castration-resistant prostate cancer (mCRPC) patients receiving [ 177 Lu]Lu-PSMA-617 therapy: Post hoc analysis of a phase II clinical trial.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Emilio Francesco Giunta, Irene Marini, Anna Sarnelli, Nicole Brighi, Flavia Foca, Giuseppe Schepisi, Cristian Lolli, Manuela Monti, Silvia Nicolini, Maria Concetta Cursano, Giovanni Rosti, Ilaria Grassi, Giovanni Paganelli, Stefano Severi, Federica Matteucci, Maddalena Sansovini, Ugo De Giorgi
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4407700565